Researchers report the identification of a new target for the PARP inhibitor drug talazoparib and show that combination treatment with talazoparib and the WEE1 inhibitor adavosertib results in enhanced anti-cancer effects.
source https://www.sciencedaily.com/releases/2021/07/210729143419.htm
Saturday, 31 July 2021
Related Posts
Macrogrid study: Big value in connecting America’s eastern and western power grids
The brain uses bodily signals to regulate fear
How ultracold, superdense atoms become invisible
Bubbling up: Previously hidden environmental impact of bursting bubbles exposed in new study
New cell database paints fuller picture of muscle repair
Extreme heat events jeopardize cardiovascular health, experts warn
0 comments: